Skip to content
healthcare.dev

Polymyxin B

NDC 25021-196, Polymyxin B Sulfate, injection, powder, lyophilized, for solution, from Sagent Pharmaceuticals.

Product NDC
25021-196
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207322
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-196 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYMYXIN B SULFATE500000 [USP'U]/1

Pharmacologic classes

Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]

Package NDCNDC-11Package
25021-196-102502101961010 VIAL in 1 CARTON (25021-196-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7dc505aa-64b0-4b7f-8ee3-2945bde40a34

Use it

Look up 25021-196 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-196 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-196. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.